326 related articles for article (PubMed ID: 15289875)
41. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
[TBL] [Abstract][Full Text] [Related]
42. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
44. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
45. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
46. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
[TBL] [Abstract][Full Text] [Related]
47. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
Chiu CC; Lin CH; Fang K
Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of Fas/Fas ligand-mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line.
Chang JS; Hsu YL; Kuo PL; Chiang LC; Lin CC
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):716-22. PubMed ID: 15554914
[TBL] [Abstract][Full Text] [Related]
49. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.
Barnhart BC; Pietras EM; Algeciras-Schimnich A; Salmena L; Sayama K; Hakem R; Peter ME
Cell Death Differ; 2005 Jan; 12(1):25-37. PubMed ID: 15499374
[TBL] [Abstract][Full Text] [Related]
50. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin.
Shiu LY; Chang LC; Liang CH; Huang YS; Sheu HM; Kuo KW
Food Chem Toxicol; 2007 Nov; 45(11):2155-64. PubMed ID: 17619073
[TBL] [Abstract][Full Text] [Related]
51. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
52. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
[TBL] [Abstract][Full Text] [Related]
54. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells.
Corbiere C; Liagre B; Terro F; Beneytout JL
Cell Res; 2004 Jun; 14(3):188-96. PubMed ID: 15225412
[TBL] [Abstract][Full Text] [Related]
55. Caspase-9 pathway activation by inhibiting endogenous fibroblast growth factor signaling in human glioma cells.
Fukushima S; Kato S; Maeda M; Shigemori M
Int J Oncol; 2008 Feb; 32(2):467-73. PubMed ID: 18202770
[TBL] [Abstract][Full Text] [Related]
56. Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells.
Zheng PW; Chiang LC; Lin CC
Life Sci; 2005 Feb; 76(12):1367-79. PubMed ID: 15670616
[TBL] [Abstract][Full Text] [Related]
57. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
58. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
59. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line.
Ohtani T; Hatori M; Ito H; Takizawa K; Kamijo R; Nagumo M
Anticancer Res; 2000; 20(5A):3117-21. PubMed ID: 11062731
[TBL] [Abstract][Full Text] [Related]
60. Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation.
Bae IH; Kang SW; Yoon SH; Um HD
Oncol Rep; 2006 May; 15(5):1175-80. PubMed ID: 16596182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
